• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

Derm In The News: February 25-March 2


Keep up with the latest headlines in dermatology from the past week, including a physician working to address the overlooked issue of skin diseases in Black patients, the initiation of a Good Laboratory Practice toxicology study for topical treatment DB-007-4, and more.

KTVU Fox 2: Highland dermatologist changing status quo on skin diseases in Black patients

In Oakland, California, Leon Clark, MD, of Wilma Chan Highland Hospital, is addressing the overlooked issue of skin diseases in Black patients, which can have deadly consequences due to misdiagnosis. Founding the dermatology department at Alameda Health System 3 years ago, Clark focuses on educating young doctors about recognizing skin conditions on all skin types, particularly emphasizing the nuances of skin of color. Despite efforts by organizations like the Skin of Color Society, a significant number of dermatologists feel inadequately trained to diagnose skin diseases in patients of color. Clark's work includes training resident physicians and conducting outreach to primary care clinics, aiming to improve health outcomes for people of color in the community.

BNN Breaking: Derm-Biome Pharmaceuticals Launches Pioneering Study for Inflammatory Skin Disease Treatment DB-007-4

Derm-Biome Pharmaceuticals Inc has initiated a Good Laboratory Practice toxicology study for its topical treatment, DB-007-4, aimed at addressing inflammatory skin diseases like acne, atopic dermatitis, and rosacea. With a focus on safety and efficacy, the study signals a response to the demand for safer treatment options amidst concerns over the side effects of current therapies. Derm-Biome progresses towards human trials with an Investigational New Drug application planned for Q2 2025.

Northwestern University: Treating Skin Cancer Without Risking Transplanted Kidneys in Organ Recipients

A clinical trial published in the Journal of Clinical Oncology revealed that specific immunosuppressants and immunotherapy alone are insufficient to prevent organ rejection in patients with skin cancer who have undergone kidney transplants. Kidney transplant recipients face a heightened risk of cancer, particularly skin cancer, yet are often excluded from drug trials due to the potential risk of organ rejection from traditional treatments. In a study administering tacrolimus and prednisone alongside cancer immunotherapy drugs, all 8 patients experienced continued tumor growth, with 1 patient suffering treatment-related organ loss.

Fox 13 Tampa Bay: Florida lawmakers propose skin cancer screenings covered by some insurance

A new bill in Tallahassee aims to alleviate the high cost of skin cancer screenings for Floridians by shifting the financial burden to insurance companies. Sponsored by Rep. Ralph Massullo and Sen. Gayle Harrell, the bill, HB 241, proposes coverage for skin cancer screenings under state group health insurance plans and health maintenance organizations. This revised approach, which targets state workers and eligible family members, marks a second attempt after a similar bill failed in 2023.

NBC News: Tweens are getting rashes from some skin care products popularized on social media, dermatologists say

Dermatologist Carol Cheng, MD, encourages fellow dermatologists to educate patients and parents about the potential risks of using such products unnecessarily and to advise simpler skin care routines for children without skin issues. Dermatologists are observing a concerning trend among tweens and young teenagers, who are experiencing skin irritations and rashes due to the use of skin care products they do not need, often influenced by social media. Brands like Drunk Elephant and Glow Recipe, popular among young consumers, may contain ingredients like retinoids and exfoliating acids that can be too harsh for youthful skin, leading to discomfort and irritation.

Have you seen any dermatology headlines this week that we may have missed? Share with us by emailing our team at DTEditor@mmhgroup.com.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.